Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2016)

Dr Reddys Laboratories (RDY) posted quarterly Times Interest Earned of $1.9 for Q4 2016, down 89.13% on a QoQ basis from $17.5 in Q1 2013.

Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2016) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Times Interest Earned for 5 consecutive years, with $1.9 the latest figure, recorded in Q4 2016.

Quarterly Times Interest Earned changed N/A year-over-year to $1.9 in Q4 2016, while the trailing twelve-month figure through Sep 2017 was $9.29 (changed N/A YoY) and the FY2026 annual result came in at $13.48, down 47.19% from the prior year.
Times Interest Earned retreated to $1.9 in Q4 2016 per RDY's latest filing, from $17.5 in the prior quarter.
Over the last five years, Times Interest Earned for RDY reached as high as $68.0 million in Q4 2012 and fell as low as $1.9 in Q4 2016.
A 3-year average of $22.7 million and a median of $17.5 in 2013 frame the typical range for Times Interest Earned.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	13.44
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-2.81
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	0.18
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-0.07
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	0.33
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	5.11
10	Dr Reddys Laboratories	9.82 Bn	9.66 Bn	-	-

Download Data